April 30 1996 - ANSWER ICH GCP Development Date
Quality - ANSWER ICH Q
Efficacy - ANSWER ICH E
Safety - ANSWER ICH S
Multidisciplinary - ANSWER ICH M
guidance for industry, consolidated guideance - ANSWER ICH E 6
Clinical Safety Data Management Definitions and Standards - ANSWER I...
CCRP SOCRA Exam Graded A+
April 30 1996 - ANSWER ICH GCP Development Date
Quality - ANSWER ICH Q
Efficacy - ANSWER ICH E
Safety - ANSWER ICH S
Multidisciplinary - ANSWER ICH M
guidance for industry, consolidated guideance - ANSWER ICH E 6
Clinical Safety Data Management Definitions and Standards - ANSWER ICH E2A
Safety pharmacology studies for human pharmaceuticals - ANSWER ICH S7A
Electronic records, electronic signatures - ANSWER 21 CFR Part 11
Informed Consent - ANSWER 21 CFR Part 50
Financial Disclosures - ANSWER 21 CFR Part 54
Institutional Review Board - ANSWER 21 CFR Part 56
IND Application - ANSWER 21 CFR 312
New Drug Application - ANSWER 21 CFR 314
Investigational Device Exemption - ANSWER 21 CFR 812
21 CFR Part 814 - ANSWER pre market approval of medical devices
45 CFR Part 46 - ANSWER Federal Research
Studies that investigate the potential undesirable PD effects of a substance on physiological functions in relation to exposure in the therapeutic range or above - ANSWER Safety Pharmacology Studies (Pre-Clinical)
1) To Identify undesirable PD properties of a substance that may have relevance to its human safety. 2) To evaluate adverse PD and/or pathophysio effects of a substance observed in toxicology studies 3)to investigate the mechanism of the adverse PD effects observed and/or suspected - ANSWER Drug Development Safety Pharmacology Study Objectives (3)
1) Cardiovascular
2)Respiratory
3)CNS - ANSWER Three vital organ considered highest priority
1) PK and toxicokinetic
2) Single dose toxicity
3) Repeated dose toxicity
4) Local tolerance
5) Genotoxicity
6) Carcinogenicity
7) Reproduction toxicity
8) Supplemental studies if needed - ANSWER Types of Non-Clinical Studies (Animal Trials)
Study that investigates the mode of action and/or effects of a drug substance in relation to its desired therapeutic target - ANSWER Primary Pharmacodynamic Studies
Studies that investigate the mode of action and/or effects of a drug substance not related to its desire therapeutic target - ANSWER Secondary Pharmacodynamic Studies
Blood Pressure
Heart Rate
ECG/EKG
Repolarization/conductance abnormalities - ANSWER Core Battery for Cardiovascular System
Respiratory Rate
Functional Assessments (tidal volume, hgb Oxygen saturation) - ANSWER Core Battery
for Respiratory System
Motor activity
behavioral changes
coordination
sensory/motor reflex response
temperature - ANSWER Core Battery for Central Nervous System
Investigational New Drug Application
FDA - ANSWER Before clinical trials can be initiated, an application containing the appropriate information must be submitted to regulatory authorities, in the USA this is called XXXX and submitted to the XXX (21 CFR Part 312) Unapproved drug to be shipped lawfully for the purpose of conducting investigations of the drug - ANSWER An IND permits what? (21 CFR Part 312)
Assuring the safety and rights of subjects - ANSWER FDA's primary objective in all phases of development is...
Phase II and III - ANSWER These phase of trials, the FDA helps assure the quality of the scientific evaluation is adequate to permit evaluation of the drugs safety and efficacy
(21 CFR Part 312)
The FDA - ANSWER Who determines if Phase II/III studies are likely to yield data capable of meeting regulatory standards for marketing approval?
1) Novelty of drug
2)Extent the drug has been studied previously
3) Known of suspected risks
4) Phase of development - ANSWER IND information depends on the amount of information available, these 4 things are: (21 CFR Part 312)
General Investigational Plan
Protocols for specific human studies - ANSWER Initial IND should focus on (21 CFR Part 312)
Build logically on previous submissions
Be supported by additional information such as animal studies and other human studies
- ANSWER Amendments to IND with new or revised protocols (21 CFR Part 312)
Cover Sheet (FDA Form 1571)
Table of Contents
Introductory statement
investigator's brochure
protocol (s)
Chemistry and manufacturing information
pharm and tox information
previous human experience with investigational drug - ANSWER A Sponsor Initiated IND must contain (21 CFR Part 312)
30 Days, unless FDA notifies sponsor of clinical hold
Upon earlier notification, investigations may begin - ANSWER How long does it take for an IND to go into effect? (21 CFR Part 312)
1) To facilitate the availability of promising new drugs available to desperately ill patients
as early in the drug development process as possible, before general marketing begins
2)To obtain additional data on the drug's safety and effectiveness - ANSWER The purpose of Treatment Use of Investigational Drug (21 CFR Part 312)
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller LUCKYSTAR2022. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £8.96. You're not tied to anything after your purchase.
